Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Adenoma » Mesothelioma
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Neoplasms, Mesothelial » Mesothelioma
Description
A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed) MeSH
Hierarchy View
Subtype Terms (2)
Mesothelioma, Malignant
121 drugs (60 approved, 61 experimental)
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (1)
Phase 2 Indicated Drugs (59)
Other Experimental Indicated Drugs (8)
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (41)
Australasian Lung Cancer Trials Group
European Organisation for Research and Treatment of Cancer
European Thoracic Oncology Platform
Groupe Hospitalier Paris Saint Joseph
Intergroupe Francophone de Cancerologie Thoracique
Moorgreen Hospital, Southampton
Organization Involved with Phase 2 Indications (133)
ASO SS Antonio e Biagio e C Arrigo Alessandria, Italy
Azienda Ospedaliera San Gerardo di Monza
Azienda Ospedaliera Universitaria Senese
Cancer and Leukemia Group B (CALGB)
Case Western Reserve University
Chao Family Comprehensive Cancer Center
City of Hope National Medical Center
Eastern Cooperative Oncology Group
Gruppo Oncologico Italiano di Ricerca Clinica
Health Pharma Professional Research
Herbert Irving Comprehensive Cancer Center
Hoosier Cancer Research Network
Institut National de la Santé Et de la Recherche Médicale, France
Istituto Clinico Humanitas - Rozzano (MI), Italy
Italian Network for Tumor Biotherapy
June Hancock Mesothelioma Research Fund
National Institutes of Health (NIH)
North Central Cancer Treatment Group
State University of New York, Buffalo
St. Vincent Medical Center - Los Angeles
Swiss Accident Insurance Fund SUVA
Swiss Group for Clinical Cancer Research
Swiss National Science Foundation
The Christie NHS Foundation Trust
Organization Involved with Phase 1 Indications (47)
CTI Clinical Trial and Consulting Services
Huazhong University of Science and Technology
Icahn School of Medicine at Mount Sinai
Organization Involved with Other Experimental Indications (2)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.